DB06225ExperimentalSmall molecule
HMR4011 (IPL 576,092) is a novel steroidal anti-inflammatory compound with a mechanism of action distinct from that of glucocorticoid. IPL 576,092 has previously been investigated as a treatment for asthma.
- Mechanism
- Curator reviewed
HMR4011 is a leukocyte suppressing/selective anti-inflammatory drug (LSAID) that was investigated for asthma treatment, a chronic inflammatory disease of the airways.
- Primary indication
- Investigated for use/treatment in asthma.Curator reviewed
- Code names
- HMR4011 · HMR4011A · IPL 576,092
Which companies are running trials of HMR4011, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account